| Cristy N Bunker, RN, FNP-C | |
|
1414 Jefferson St, Medical, Pasadena, TX 77506 | |
| (713) 475-3780 | |
| Not Available |
| Full Name | Cristy N Bunker |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1414 Jefferson St, Pasadena, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063745321 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 647117 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cristy N Bunker, RN, FNP-C 1414 Jefferson Street; Attn;medical, Chevron Phillips Chemical, Pasadena, TX 77506 Ph: (713) 475-3780 | Cristy N Bunker, RN, FNP-C 1414 Jefferson St, Medical, Pasadena, TX 77506 Ph: (713) 475-3780 |
News Archive
The U.S. Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).
To participate successfully in life, it is important to be able to read and write. Nevertheless, many children and adults have difficulties in acquiring these skills and the reason is not always obvious. They suffer from dyslexia which can have a variety of symptoms. Thanks to research carried out by Bego-a D-az and her colleagues at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, a major step forward has been made in understanding the cause of dyslexia.
An international study reviewed methods of cardiopulmonary resuscitation (CPR) in an attempt to save lives and reduce neurological damage.
A consortium of researchers led by Monash University will receive more than $3.5 million in Australian Government funding for research into the use of aspirin for reducing heart attacks, strokes and dementia in older Australians.
BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.
› Verified 3 days ago
Guillermo Marquez Macias Sr., Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 908 Southmore Ave Ste 100, Pasadena, TX 77502 Phone: 713-554-1091 | |
Daniel Dao, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5763 Fairmont Pkwy, Pasadena, TX 77505 Phone: 346-320-1800 | |
Harold Bryan Lee, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 7720 Spencer Hwy, Pasadena, TX 77505 Phone: 281-476-9900 Fax: 281-479-1320 | |
Mr. Mario Alberto Rodriguez Jr., AGACNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 4000 Spencer Hwy, Pasadena, TX 77504 Phone: 713-359-2000 | |
Renee Tabuena, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4750 Fairmont Pkwy, Pasadena, TX 77504 Phone: 281-732-4911 | |
Melissa Vanessa Gonzalez, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3050 Crenshaw Rd, Suite 120, Pasadena, TX 77505 Phone: 832-448-6098 Fax: 713-944-3141 | |
Delia Xiomara Udave, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4024 Brookhaven Ave, Pasadena, TX 77504 Phone: 713-944-2324 Fax: 713-944-1539 |